Evidence-based therapy for heart failure

Heart failure (HF) is a major public health problem associated with increased morbidity and mortality. As the US life expectancy increases and the population ages, the overall prevalence of HF will continue to escalate. The increasing use of effective selective therapies such as neurohormonal blocka...

Full description

Saved in:

Bibliographic Details
Published in:	The Medical clinics of North America Vol. 96; no. 5; p. 915
Main Authors:	Deedwania, Prakash C, Carbajal, Enrique
Format:	Journal Article
Language:	English
Published:	United States 01.09.2012
Subjects:	Adrenergic beta-Antagonists - therapeutic use Angiotensin-Converting Enzyme Inhibitors - therapeutic use Evidence-Based Medicine Heart Failure - drug therapy Heart Failure - physiopathology Hospitalization Humans Renin-Angiotensin System - drug effects Renin-Angiotensin System - physiology Vasodilator Agents - therapeutic use Ventricular Dysfunction, Left - drug therapy
ISSN:	1557-9859, 1557-9859
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Heart failure (HF) is a major public health problem associated with increased morbidity and mortality. As the US life expectancy increases and the population ages, the overall prevalence of HF will continue to escalate. The increasing use of effective selective therapies such as neurohormonal blockade in the treatment of patients with HF has led to considerable improvement in their prognosis. During the past several decades, some studies have demonstrated the benefits of treatment; based on the evidence available from these studies, various national and international guidelines have specific recommendations for the evidence-based therapy with these drugs in patients with HF.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23
ISSN:	1557-9859 1557-9859
DOI:	10.1016/j.mcna.2012.07.010